Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer
Conditions
- Advanced Cancer
- Gastric Cancer
- Breast Cancer
- Pancreatic Cancer
- Prostate Cancer Metastatic
- Colo-rectal Cancer
- Solid Tumor
- Solid Carcinoma
- Solid Carcinoma of Stomach
- Cancer of Stomach
- Lymphoma
- Sarcoma
- Cutaneous T Cell Lymphoma
- Head and Neck Squamous Cell Carcinoma
- Basal Cell Carcinoma
- Cutaneous T-cell Lymphoma
- Cutaneous Squamous Cell Carcinoma
Interventions
- DRUG: GZ17-6.02
- DRUG: Capecitabine
Sponsor
Genzada Pharmaceuticals USA, Inc.
Collaborators